Submit a Manuscript to the Journal

Journal of Inflammation Research

For an Article Collection on

Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation

Manuscript deadline

Article collection guest advisor(s)

Prof. Ning Quan, Florida Atlantic University

Submit an ArticleVisit JournalArticles

Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation

The Journal of Inflammation Research is pleased to announce a new Article Collection dedicated to the role of anti-inflammatory biologics in the treatment of chronic inflammatory conditions.

This Collection, edited by the Editor-In-Chief Prof. Ning Quan, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Chronic inflammation is the hallmark of many diseases. These conditions can be crippling to patients. Traditional anti-inflammatory drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, are non-specific, causing further systemic problems with continued use. By contrast, biologic therapies harness the specificity necessary to relieve inflammation while also reducing off-target and non-specific effects.

While this call is open to receive manuscripts highlighting all anti-inflammatory biologics, the Editors are particularly interested in manuscripts relating to the following areas:

  • Tumor necrosis factor inhibitors
  • Interleukin inhibitors
  • Monoclonal antibody specificity studies
  • Novel mechanisms of action of new candidate biologics
  • The role of biosimilars in treating inflammatory disease
  • Indications and contraindications
  • Cell-based therapies to quell inflammation

Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission: OTIPZ. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Ashley Ambros.

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

The deadline for submitting manuscripts is 01 April 2026.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

Looking to Publish your Research?

Find out how to publish your research open access with Taylor & Francis Group.

Choose open access

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.